Literature DB >> 25662354

Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING study.

Roberta Lanzillo1, Marcello Moccia2, Antonio Carotenuto2, Veria Vacchiano2, Barbara Satelliti2, Valentina Panetta3, Vincenzo Brescia Morra2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25662354     DOI： 10.1177/1352458514562989

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  2 in total

1.  An update on Peginterferon beta-1a Management in Multiple Sclerosis: results from an interdisciplinary Board of German and Austrian Neurologists and dermatologists.

Authors:  Annette Kolb-Mäurer; Cord Sunderkötter; Borries Kukowski; Sven G Meuth
Journal:  BMC Neurol       Date:  2019-06-15       Impact factor: 2.474

2.  A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.

Authors:  Roberta Lanzillo; Luca Prosperini; Claudio Gasperini; Marcello Moccia; Roberta Fantozzi; Carla Tortorella; Viviana Nociti; Pietro Annovazzi; Paola Cavalla; Marta Radaelli; Simona Malucchi; Valentina Torri Clerici; Laura Boffa; Fabio Buttari; Paolo Ragonese; Giorgia Teresa Maniscalco; Massimiliano Di Filippo; Maria Chiara Buscarinu; Federica Pinardi; Antonio Gallo; Giancarlo Coghe; Ilaria Pesci; Alice Laroni; Alberto Gajofatto; Massimiliano Calabrese; Valentina Tomassini; Eleonora Cocco; Claudio Solaro
Journal:  J Neurol       Date:  2018-03-16       Impact factor: 4.849
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.